There are approximately 17,000 people in the United States living with the progressive neuromuscular disease amyotrophic lateral sclerosis (ALS). The exact cause for ALS is still unknown; about 10%-15% of cases have known genetic causes (familial ALS), while the remaining cases have no clear cause (sporadic ALS). In people with the disease, motor neurons (muscle-controlling […]

James Woody, MD, PhD, explains the benefits of treating Dupuytren’s disease with anti-tumor necrosis factor (TNF). Rheumatology Network interviewed James Woody, MD, PhD, to discuss the recent positive results of treating Dupuytren’s disease with anti-tumor necrosis factor (TNF). Woody is the CEO of 180 Life Sciences.  

Tony Clapsis, SVP and General Manager, CVS Clinical Trial Services, reflects on industry’s progress. May 20 is celebrated internationally as Clinical Trials Day, an effort led by the Association of Clinical Research Professionals (“ACRP”) to recognize and honor the dedication of clinical research professionals and the important role they play in conducting clinical research to […]